Former MedImmune Employees Leading In the BioHealth Capital Region and Beyond In a recent conversation someone shared the quote “You can’t throw a stone in the BioHealth Capital Region and [….]
5 Questions with Stephanie Duatschek, Biopharma Executive Management Consultant “5 Questions With……” is a new BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to [….]
5 Questions with Jennifer Butler, Executive Vice President and General Manager of Innate Pharma U.S. “5 Questions With……” is a new BioBuzz series where we reach out to interesting people [….]
5 Questions With John Trainer, CFO, NexImmune, Inc. “5 Questions With……” is a new BioBuzz series where we reach out to interesting people in the BioHealth Capital Region to share [….]
BHCR Retains #4 Ranking in GEN’s Top 10 U.S. Biopharma Clusters – Here’s Why. “Top 3 By 2023” has been the slogan for the Biohealth Capital Region (BHCR) over the [….]
BioHealth Capital Region is Entering Period of “Creative Destruction” at Perfect Time March 12, 2019 In 1942, Austrian economist Joseph Schumpeter wrote, “ …industrial mutation—if I may use that biological [….]
Viela Bio’s Spinout Story Reveals A Roadmap for Growth Ahead November 6, 2018 In order: Elizabeth Parsons (Member, Mintz Levin), Aaron Ren (Head of BD and Operations, Viela Bio), Christian [….]
Q&A with Jaime Rodriguez-Canales, M.D., FEBP Dr. Rodriguez-Canales is a Senior Pathologist at MedImmune, and Course Director for the recent Multiplex Immunofluorescence in Immune-Oncology Symposium, a Bio-Trac program cosponsored by [….]
Inaugural Investment Conference Marks Inflection Point for the BioHealth Capital Region The first Biohealth Capital Region Investment Conference kicks off this week in Montgomery County. The conference marks an important [….]
Immune-Oncology Symposium
